2018
5/13/2022
5/13/2022
Q1 Trading Update for the three months ended 31 March 2018
5/13/2022
5/13/2022
Convatec announces changes within its U.S. Home Distribution Group
5/13/2022
5/13/2022
Convatec announces 2018 Interim Results
5/13/2022
5/13/2022
03 July 2018 - Board Changes
5/13/2022
5/13/2022
Convatec Receives U.S. FDA 510(k) Clearance for Avelle™ Negative Pressure Wound Therapy System
5/13/2022
5/13/2022
Trading update for the three months ended 30 September 2018 and change in FY 2018 guidance
5/13/2022
5/13/2022
Retirement of Chief Executive Officer and appointment of Rick Anderson as Chief Executive Officer (Interim)
5/13/2022
5/13/2022
US FDA 510(k) clearance for AQUACEL™ Ag Advantage
5/13/2022
5/13/2022
